Companies
From start-ups to market leaders, access critical company intelligence on a global scale
Experience what our solutions have to offer with free access to highlights of our data, insights and analysis.
From start-ups to market leaders, access critical company intelligence on a global scale
From industry deep dives to global trends, access authoritative research from our experts
Uncover your next opportunity with trusted data & insights that cut across industries
Discover the disruptive forces shaping tomorrow's world, today
Explore our diverse collection of unique datasets and find the advantage you need
Get clarity into the latest emerging themes with our reports
Experience what our solutions have to offer with free access to highlights of our data, insights and analysis.
From start-ups to market leaders, access critical company intelligence on a global scale
From industry deep dives to global trends, access authoritative research from our experts
Uncover your next opportunity with trusted data & insights that cut across industries
Discover the disruptive forces shaping tomorrow's world, today
Explore our diverse collection of unique datasets and find the advantage you need
Get clarity into the latest emerging themes with our reports
Inflammatory Bowel Disease Market Report
Ulcerative colitis is an IBD characterized by long-lasting inflammation and ulcers in the lining of the colon.
Our Inflammatory Bowel Disease market report provides an overview of the risk factors, comorbidities, and global trends for UC in the 7 major markets. In UC, symptoms can vary depending on the severity of the disease and the part of the colon that is inflamed. Due to the currently unknown etiology of UC, there is no known cure for the disease.
Our Inflammatory Bowel Disease market report, ‘Ulcerative Colitis: Epidemiology Forecast to 2026’ includes a 10-year epidemiological forecast for the diagnosed incident cases, diagnosed prevalent cases, undiagnosed prevalent cases, and total prevalent cases (both diagnosed and undiagnosed) of UC, segmented by sex and age (starting at ages 0–9 years and ending at ages 80 years and older) in the 7 major markets (7MM).
UC is a common disease across the world; however, data on the incidence and prevalence of the disease are limited by the lack of gold-standard criteria for diagnosis, disease misclassification, and inconsistent case ascertainment.
GlobalData epidemiologists have utilized national databases and robust peer-reviewed journals to build the UC forecast in the 7MM. Our epidemiology forecast report is in-depth, high quality, and market-driven, providing expert analysis of disease trends in the 7MM.